DE3683861D1 - Verfahren zur konjugierung von metallothionein mit biologisch aktiven molekuelen. - Google Patents

Verfahren zur konjugierung von metallothionein mit biologisch aktiven molekuelen.

Info

Publication number
DE3683861D1
DE3683861D1 DE8686104523T DE3683861T DE3683861D1 DE 3683861 D1 DE3683861 D1 DE 3683861D1 DE 8686104523 T DE8686104523 T DE 8686104523T DE 3683861 T DE3683861 T DE 3683861T DE 3683861 D1 DE3683861 D1 DE 3683861D1
Authority
DE
Germany
Prior art keywords
metallothionein
conjugating
biologically active
active molecules
metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686104523T
Other languages
English (en)
Inventor
Richard Albert Hadjian
Cynthia Ann Drozynski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of DE3683861D1 publication Critical patent/DE3683861D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Optics & Photonics (AREA)
  • Steroid Compounds (AREA)
DE8686104523T 1985-04-03 1986-04-02 Verfahren zur konjugierung von metallothionein mit biologisch aktiven molekuelen. Expired - Fee Related DE3683861D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71943685A 1985-04-03 1985-04-03

Publications (1)

Publication Number Publication Date
DE3683861D1 true DE3683861D1 (de) 1992-03-26

Family

ID=24890070

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686104523T Expired - Fee Related DE3683861D1 (de) 1985-04-03 1986-04-02 Verfahren zur konjugierung von metallothionein mit biologisch aktiven molekuelen.

Country Status (15)

Country Link
EP (1) EP0196669B1 (de)
JP (1) JPS61236733A (de)
KR (1) KR930003312B1 (de)
AT (1) ATE72569T1 (de)
AU (1) AU603981B2 (de)
DE (1) DE3683861D1 (de)
DK (1) DK148586A (de)
ES (1) ES8800437A1 (de)
FI (1) FI861424A (de)
GR (1) GR860876B (de)
IE (1) IE58425B1 (de)
IL (1) IL78377A0 (de)
MX (1) MX168179B (de)
NO (1) NO167124C (de)
ZA (1) ZA862417B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US5759515A (en) * 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications
US5700444A (en) * 1992-02-20 1997-12-23 Rhomed Incorporated Chemotactic peptide pharmaceutical applications
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes
US5194594A (en) * 1990-09-07 1993-03-16 Techniclone, Inc. Modified antibodies
CA2048078A1 (en) * 1990-11-15 1992-05-16 Wolfgang A. Wrasidlo Chemical modification of antibodies for creation of immunoconjugates
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5738838A (en) * 1992-02-20 1998-04-14 Rhomed Incorporated IKVAV peptide radiopharmaceutical applications
DK0629133T3 (da) * 1992-01-03 2001-04-02 Rhomed Inc Farmaceutisk anvendelse af peptidmetalioner
CN1314966C (zh) * 2004-12-03 2007-05-09 湖南农业大学 一种猪金属硫蛋白的检测方法
JP5202443B2 (ja) * 2009-06-01 2013-06-05 興和株式会社 有害金属測定試薬及び測定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
JP2871813B2 (ja) * 1990-07-03 1999-03-17 古河電気工業株式会社 クロスヘッドの角度調整装置

Also Published As

Publication number Publication date
JPS61236733A (ja) 1986-10-22
ATE72569T1 (de) 1992-02-15
MX168179B (es) 1993-05-10
IE58425B1 (en) 1993-09-22
DK148586A (da) 1986-10-04
KR860008203A (ko) 1986-11-12
KR930003312B1 (ko) 1993-04-26
AU603981B2 (en) 1990-12-06
ZA862417B (en) 1987-12-30
EP0196669A3 (en) 1988-09-14
AU5552486A (en) 1986-10-09
IE860853L (en) 1986-10-03
ES553685A0 (es) 1987-10-16
FI861424A0 (fi) 1986-04-02
FI861424A (fi) 1986-10-04
NO861200L (no) 1986-10-06
GR860876B (en) 1986-07-29
EP0196669B1 (de) 1992-02-12
NO167124B (no) 1991-07-01
DK148586D0 (da) 1986-04-02
EP0196669A2 (de) 1986-10-08
ES8800437A1 (es) 1987-10-16
NO167124C (no) 1991-10-09
IL78377A0 (en) 1986-07-31

Similar Documents

Publication Publication Date Title
DE3683861D1 (de) Verfahren zur konjugierung von metallothionein mit biologisch aktiven molekuelen.
DE3684835D1 (de) Verfahren fuer die gleichzeitige absorption von schwefeloxyden und herstellung von ammoniumsulfat.
FI103278B1 (fi) Menetelmä biologisesti aktiivisen TGF- :n kaltaisen proteiinin tuottamiseksi
ATA136979A (de) Verfahren zur herstellung von neuen 4-pyridon-3- carbonsaeuren und/oder deren derivaten
ATE65185T1 (de) Thrombolytische zusammensetzung und verfahren zu deren herstellung.
ATA91980A (de) Verfahren zur herstellung von neuen penemcarbonsaeuren und deren salzen
DE3675134D1 (de) Verfahren zur herstellung von 2,5-dicetopiperazinen.
ATA121090A (de) Verfahren zur herstellung von allantoin
ATA185286A (de) Verfahren zur herstellung von neuen psychogeriatrischen diazinylpiperidinderivaten von cyclischen amiden und imiden sowie von deren saeureadditionssalzen
AT360678B (de) Verfahren zur herstellung von neuen angiotensin -ii-antagonistisch wirkenden peptiden sowie von deren saeureadditionssalzen und komplexen
DE3872228D1 (de) Elektrode fuer die entwicklung von sauerstoff und deren herstellungsverfahren.
DE68913855D1 (de) Verfahren zur Herstellung von dimeren Alkaloiden.
ATE151754T1 (de) Verfahren für die synthese von 2,6-dichlor-5- fluornicotinsäure und 2,6-dichlor-5- fluornicotinoylchlorid
AT360530B (de) Verfahren zur herstellung von neuen 3,5- disubstituierten-1h-1,2,4-triazolen und von deren salzen mit pharmazeutisch verwendbaren saeuren
PT81443A (de) Verfahren zur herstellung von corticosteroid-21-phosphorsaeuren und deren salzen und die corticosteroid-21-phosphorsaeuretriester
DE3761372D1 (de) Verfahren zur herstellung von zirkoniumcarboxylat.
AT387540B (de) Verfahren und vorrichtung zur herstellung von in zwei richtungen orientierten, waermeschrumpfenden schlauchfolien
DE68908843D1 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
ATE77102T1 (de) Verfahren zur reinigung sowie pasteurisierung von urokinase.
DE3762337D1 (de) Verfahren zur herstellung von reinen hydroxylammoniumsalzen von fettsaeuren mit 1 bis 4 kohlenstoffatomen.
DE69002872T2 (de) Verfahren zur Erhöhung der Zytotoxizität von Anthracyclinen durch Photoaktivierung.
DD255643A3 (de) Verfahren und vorrichtung fuer die herstellung von schaumweinen im kontinuierlichen strom
ATA200289A (de) Verfahren zur herstellung von neuen 5- fluornicotinsaeuren oder von deren derivaten und salzen
PT82277A (en) Method for enhancement of absorption of proteins with medicinal properties
ATA721978A (de) Verfahren zur herstellung von neuen 2-hydroxy- alkyl-2'-aminoalkyldiphenylsulfiden und deren saeureadditionssalzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee